Clinical risk factors for portopulmonary hypertension†

2008286 citationsJournal Articlegreen Open Access

Authors

Steven M. Kawut · Columbia University

Michael J. Krowka · Mayo Clinic in Arizona

James F. Trotter · University of Colorado Denver

Kari E. Roberts · Tufts Medical Center

Raymond L. Benza · University of Alabama at Birmingham

David B. Badesch · University of Colorado Denver

Darren B. Taichman

Abstract

Female sex and autoimmune hepatitis were associated with an increased risk of portopulmonary hypertension, whereas hepatitis C infection was associated with a decreased risk in patients with advanced liver disease. Hormonal and immunologic factors may therefore be integral to the development of portopulmonary hypertension.

Topics & Keywords

Pulmonary Hypertension Research and Treatments Liver Disease and Transplantation Liver Disease Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Hepatology

Volume 48, Issue 1, pp. 196-203

DOI: 10.1002/hep.22275

Field-Weighted Citation Impact: 13.95